Pharmaceutical Care for A Patient with Brucella Infective Endocarditis and Spondylitis

OBJECTIVE To explore the therapeutic regimen of brucella infective endocarditis with spondylitis and the role of clinical pharmacists in the treatment. METHODS By participating in the treatment process of a patient with brucella infectious endocarditis and spondylitis, clinical pharmacists assisted clinicians to establish medication regimen combined with genetic testing and INR monitoring results. In view of the anticoagulant effect caused by drug interaction, pharmacists adjusted the warfarin dose timely in order to achieve the ideal target, provided patients effective pharmaceutical care and medical education at the same time. RESULTS The clinicians adopted the treatment suggestions proposed by clinical pharmacists and no adverse reactions occurred during the treatment. After the condition was improved, the patient was discharged. CONCLUSION Clinical pharmacists play a positive role in clinical therapy by implementing whole-process pharmaceutical care for patients.